Provided by Tiger Fintech (Singapore) Pte. Ltd.

Monte Rosa Therapeutics

6.29
+0.23003.80%
Post-market: 6.290.00000.00%16:04 EST
Volume:827.64K
Turnover:5.04M
Market Cap:386.43M
PE:-3.56
High:6.40
Open:5.89
Low:5.86
Close:6.06
Loading ...

Monte Rosa Therapeutics price target raised to $20 from $16 at Piper Sandler

TIPRANKS
·
28 Oct 2024

Wedbush Adjusts Price Target on Monte Rosa Therapeutics to $15 From $11, Maintains Outperform Rating

MT Newswires Live
·
28 Oct 2024

Monte Rosa Therapeutics Inc : Wedbush Raises Target Price to $15 From $11

THOMSON REUTERS
·
28 Oct 2024

PROCEPT BioRobotics Posts Strong Q3 Earnings, Joins Monte Rosa Therapeutics, EyePoint Pharmaceuticals And Other Big Stocks Moving Higher On Monday

Benzinga
·
28 Oct 2024

BUZZ-Monte Rosa Therapeutics surges on licensing deal with Novartis

Reuters
·
28 Oct 2024

Monte Rosa Therapeutics Shares up 30% After Co Signs Licensing Deal With Novartis

THOMSON REUTERS
·
28 Oct 2024

Traders Eye Big Tech Earnings, Lifting US Equity Futures Pre-Bell

MT Newswires Live
·
28 Oct 2024

Novartis to pay Monte Rosa $150 million upfront to develop a new class of drugs

Reuters
·
28 Oct 2024

Why Is Monte Rosa Therapeutics Stock Surging On Monday?

Benzinga
·
28 Oct 2024

Top Premarket Gainers

MT Newswires Live
·
28 Oct 2024

Monte Rosa Therapeutics Enters Global License Deal With Novartis; Shares Jump Pre-Bell

MT Newswires Live
·
28 Oct 2024

BRIEF-Monte Rosa Therapeutics Announces Global License Pact With Novartis To Advance T And B Cell-Modulating Vav1-Directed Molecular Glue Degraders

Reuters
·
28 Oct 2024

Monte Rosa Therapeutics Announces Global License Agreement With Novartis to Advance T and B Cell-Modulating Vav1-Directed Molecular Glue Degraders

THOMSON REUTERS
·
28 Oct 2024

Monte Rosa Therapeutics: Global License Pact With Novartis to Advance T and B Cell-Modulating Vav1-Directed Molecular Glue Degraders

THOMSON REUTERS
·
28 Oct 2024

Monte Rosa Therapeutics: Novartis to Obtain Worldwide Rights to Develop, Manufacture & Commercialize Mrt-6160 and Other Vav1 Mgds

THOMSON REUTERS
·
28 Oct 2024

Monte Rosa Therapeutics: Co to GET up-Front Payment of $150 Mln & Eligible to GET Milestone Payments

THOMSON REUTERS
·
28 Oct 2024